Smith & Wesson Brands Posts Weak Q4 Results, Joins Aptevo Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Group 1 - U.S. stock futures are lower, with Dow futures down approximately 0.2% [1] - Smith & Wesson Brands reported fourth-quarter revenue of $140.8 million, missing analyst estimates of $152.41 million [2] - The company reported adjusted earnings of 20 cents per share, falling short of estimates of 23 cents per share [2] Group 2 - Smith & Wesson Brands shares fell 12.6% to $9.51 in pre-market trading [2] - Regencell Bioscience Holdings Ltd shares dropped 16.2% to $52.96 in pre-market trading [4] - QuantaSing Group Ltd- ADR shares fell 12.1% to $11.86 in pre-market trading [4] - Aptevo Therapeutics Inc shares decreased by 11.9% to $4.52 in pre-market trading [4] - Capricor Therapeutics Inc shares fell 7.4% to $11.04 in pre-market trading [4] - Mesoblast Ltd shares declined 6.5% to $10.94 in pre-market trading [4] - Diginex Limited shares dropped 6.5% to $43.51 in pre-market trading [4] - Himalaya Shipping Ltd. shares decreased 6.3% to $6.22 in pre-market trading [4] - AIRO Group Holdings, Inc. shares fell 5.3% to $24.88 in pre-market trading [4]